AbCellera Biologics (ABCL) Assets (2020 - 2026)
AbCellera Biologics (ABCL) posted Assets of $1.31 billion for Q2 2026, down 6.7% from $1.4 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, AbCellera Biologics' Assets came in at $1.36 billion, down 0.3% from FY2024.
- Annual Assets has declined for three consecutive years, though with a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
- In prior years, AbCellera Biologics' Assets was $1.36 billion in FY2024 (-8.6%), $1.49 billion in FY2023 (-3.4%), $1.54 billion in FY2022 (+16.9%) and $1.32 billion in FY2021 (+31.1%).
- Quarterly Assets has run from a low of $1.17 billion in Q3 2021 to a high of $1.59 billion in Q2 2022 over five years.
- On a year-over-year basis, Assets has declined in each of the last 14 quarters, with an average decline of 4.7% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q1 2022, with growth of 41.1%; the weakest was Q4 2024, with a decline of 8.6%.
- According to Business Quant data, Assets for the three prior quarters was $1.31 billion (Q1 2026), $1.36 billion (Q4 2025) and $1.36 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 27.42 Bn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Bn |
| Mar 31, 2026 | 1.31 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.40 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.39 Bn |
| Jun 30, 2024 | 1.41 Bn |
| Mar 31, 2024 | 1.46 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.50 Bn |
| Dec 31, 2022 | 1.54 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jun 30, 2022 | 1.59 Bn |
| Mar 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 1.32 Bn |
| Sep 30, 2021 | 1.17 Bn |
API Access
AbCellera Biologics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();